BEIJING – The U.S. Food and Drug Administration will open three offices in China this week in an unprecedented effort to improve the safety of exports headed to America amid recurring product safety scares. The new FDA offices, which are the first outside of the United States, will increase effectiveness in protecting for American and Chinese consumers, according to the office of U.S. Health and Human Services Secretary Mike Leavitt. Full Story
About OODA Analyst
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.